Inducible macropinocytosis of hyaluronan in B16-F10 melanoma cells

Matrix Biology

Volumn 29, Issue 6, 2010, Pages 503-510

  Greyner, Henry J ^a,b   Wiraszka, Tomasz ^b   Zhang, Li Shu ^a,b   Petroll, W Matthew ^b   Mummert, Mark E ^a,b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

B16 F10 melanoma; CD44; Endocytosis; Hyaluronan; Macropinocytosis

Indexed keywords

COPOLYMER; HERMES ANTIGEN; HYALURONIC ACID;

ARTICLE; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG INHIBITION; ELECTRON MICROSCOPY; FLUORESCENCE; MACROPINOCYTOSIS; MELANOMA CELL; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; CELL LINE, TUMOR; CHONDROCYTES; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MELANOMA, EXPERIMENTAL; MICE; PINOCYTOSIS;

EID: 77956455687     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2010.06.004     Document Type: Article

References (47)

1. Aguiar D.J., Knudson W., Knudson C.B. Internalization of the hyaluronan receptor CD44 by chondrocytes. Exp. Cell Res. 1999, 252:292-302.
2. Ahrens T., Assmann V., Fieber C., Termeer C., Herrlich P., Hofmann M., et al. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J. Investig. Dermatol. 2001, 116:93-101.
3. Ahrens T., Sleeman J.P., Schempp C.M., Howells N., Hofmann M., Ponta H., et al. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 2001, 20:3399-3408.
4. Bergman K., Elvingson C., Hilborn J., Svensk G., Bowden T. Hyaluronic acid derivatives prepared in aqueous media by triazine-activated amidation. Biomacromolecules 2007, 8:2190-2195.
5. Bourguignon L.Y., Lokeshwar V.B., Chen X., Kerrick W.G. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J. Immunol. 1993, 151:6634-6644.
6. Collis L., Hall C., Lange L., Ziebell M., Prestwich R., Turley E.A. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action. FEBS Lett. 1998, 440:444-449.
7. Culty M., Shizari M., Thompson E.W., Underhill C.B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. Cell. Physiol. 1994, 160:275-286.
8. de Belder A.N., Wik K.O. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res. 1975, 44:251-257.
9. Deed R., Rooney P., Kumar P., Norton J.D., Smith J., Freemont A.J., et al. Early-response gene signaling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 1997, 71:251-256.
10. English N.M., Lesley J.F., Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 1998, 58:3736-3742.
11. Evanko S.P., Wight T.N. Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 1999, 47:1331-1342.
12. Fan T.C., Chang H.T., Chen I.W., Wang H.Y., Chang M.D. A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 2007, 8:1778-1795.
13. Fretz M., Jin J., Conibere R., Penning N.A., Al-Taei S., Storm G., et al. Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV-TAT peptide and octaarginine. J. Control. Release 2006, 116:247-254.
14. Harris E.N., Weigel P.H. The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E. Glycobiology 2008, 18:638-648.
15. Hewlett L.J., Prescott A.R., Watts C. The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 1994, 124:689-703.
16. Hua Q., Knudson C.B., Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci. 1993, 106:365-375.
17. Ichikawa T., Itano N., Sawai T., Kimata K., Koganehira Y., Saida T., et al. Increased synthesis of hyaluronate enhances motility of human melanoma cells. J. Investig. Dermatol. 1999, 113:935-939.
18. Ionov R., El Abed A., Goldmann M., Peretti P. Interactions of lipid monolayers with the natural biopolymer hyaluronic acid. Biochim. Biophys. Acta 2004, 1667:200-207.
19. Jiang H., Peterson R.S., Wang W., Bartnik E., Knudson C.B., Knudson W. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J. Biol. Chem. 2002, 277:10531-10538.
20. Jones A.T. Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides. J. Cell. Mol. Med. 2007, 11:670-684.
21. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 1997, 9:635-642.
22. Knudson W. The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue. Front. Biosci. 1998, 3(1093-4715):D604-D615.
23. Kultti A., Rilla K., Tiihonen R., Spicer A.P., Tammi R.H., Tammi M.I. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J. Biol. Chem. 2006, 281:15821-15828.
24. Kyosseva S.V., Harris E.N., Weigel P.H. The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases. J. Biol. Chem. 2008, 283:15047-15055.
25. Laurent U.B., Dahl L.B., Reed R.K. Catabolism of hyaluronan in rabbit skin takes place locally, in lymph nodes and liver. Exp. Physiol. 1991, 76:695-703.
26. Laurent U.B., Fraser J.R., Engstrom-Laurent A., Reed R.K., Dahl L.B., Laurent T.C. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 1992, 12:130-136.
27. Mummert M.E., Mohamadzadeh M., Mummert D.I., Mizumoto N., Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med. 2000, 192:769-779.
28. Mummert M.E., Mummert D.I., Ellinger L., Takashima A. Functional roles of hyaluronan in b16-f10 melanoma growth and experimental metastasis in mice. Mol. Cancer Ther. 2003, 2:295-300.
29. Nakata M., Smyth M.J., Norihisa Y., Kawasaki A., Shinkai Y., Okumura K., et al. Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo. J. Exp. Med. 1990, 172:1877-1880.
30. Racoosin E.L., Swanson J.A. Macropinosome maturation and fusion with tubular lysosomes in macrophages. J. Cell Biol. 1993, 121:1011-1020.
31. Rudrabhatla S.R., Mahaffey C.L., Mummert M.E. Tumor microenvironment modulates hyaluronan expression: the lactate effect. J. Investig. Dermatol. 2006, 126:1378-1387.
32. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995, 182:389-400.
33. Samuelsson C., Gustafson S. Studies on the interaction between hyaluronan and a rat colon cancer cell line. Glycoconj. J. 1998, 15:169-175.
34. Savani R.C., Wang C., Yang B., Zhang S., Kinsella M.G., Wight T.N., et al. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin. Investig. 1995, 95:1158-1168.
35. Savani R.C., Cao G., Pooler P.M., Zaman A., Zhou Z., DeLisser H.M. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 2001, 276:36770-36778.
36. Scholl F.G., Gamallo C., Vilaro S., Quintanilla M. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J. Cell Sci. 1999, 112(Pt 24):4601-4613.
37. Seib F.P., Jones A.T., Duncan R. Comparison of endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J. Cont. Rel. 2007, 117:291-300.
38. Stahl A., Mueller B.M. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell Biol. 1995, 129:335-344.
39. Steinert S., Lee E., Tresset G., Zhang D., Hortsch R., et al. A fluorescent glycolipid-binding peptide probe traces cholesterol dependent microdomain-derived trafficking pathways. PLoS ONE 2008, 3:e2933.
40. Swanson J.A. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J. Cell Sci. 1989, 94(Pt 1):135-142. 0021-9533.
41. Swanson J.A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol. 2008, 9:639-649.
42. Swanson J.A., Watts C. Macropinocytosis. Trends Cell Biol. 1995, 5:424-428.
43. Tammi R., Rilla K., Pienimaki J.P., MacCallum D.K., Hogg M., Luukkonen M., et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 2001, 276:35111-35122.
44. Thankamony S.P., Knudson W. Acylation of CD44 and its association with lipid rafts are required for receptor and hyaluronan endocytosis. J. Biol. Chem. 2006, 281:34601-34609.
45. 1 receptors. J. Cell Biol. 1990, 110:1211-1215.
46. Zhang L., Underhill C.B., Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 1995, 55:428-433.
47. Zhou B., Weigel J.A., Fauss L., Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 2000, 275:37733-37741.